State Street Corp Buys New Position in Astrana Health, Inc. (NASDAQ:ASTH)

State Street Corp bought a new stake in shares of Astrana Health, Inc. (NASDAQ:ASTH) during the 3rd quarter, according to its most recent filing with the SEC. The firm bought 1,587,270 shares of the company’s stock, valued at approximately $91,966,000.

Several other hedge funds have also modified their holdings of ASTH. Central Pacific Bank Trust Division purchased a new stake in shares of Astrana Health during the 3rd quarter valued at about $160,000. SG Americas Securities LLC purchased a new stake in shares of Astrana Health during the 3rd quarter valued at about $680,000. Granite Bay Wealth Management LLC purchased a new stake in shares of Astrana Health during the 3rd quarter valued at about $290,000. Handelsbanken Fonder AB purchased a new stake in shares of Astrana Health during the 3rd quarter valued at about $492,000. Finally, GAMMA Investing LLC purchased a new stake in shares of Astrana Health during the 3rd quarter valued at about $34,000. 52.77% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of brokerages have weighed in on ASTH. Robert W. Baird raised their price objective on Astrana Health from $67.00 to $86.00 and gave the company an “outperform” rating in a research note on Wednesday, November 13th. KeyCorp began coverage on Astrana Health in a research note on Friday, October 11th. They set a “sector weight” rating for the company. BTIG Research raised their price objective on Astrana Health from $60.00 to $70.00 and gave the company a “buy” rating in a research note on Thursday, October 3rd. Finally, TD Cowen began coverage on Astrana Health in a research note on Monday, October 14th. They set a “buy” rating and a $66.00 price objective for the company. One equities research analyst has rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and an average price target of $65.17.

Astrana Health Price Performance

Shares of ASTH opened at $36.80 on Tuesday. Astrana Health, Inc. has a 52 week low of $34.11 and a 52 week high of $63.20. The firm has a market cap of $2.07 billion, a price-to-earnings ratio of 28.30, a PEG ratio of 1.80 and a beta of 1.13. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60. The stock has a 50 day moving average of $49.04 and a 200-day moving average of $48.12.

Astrana Health (NASDAQ:ASTH) last released its quarterly earnings data on Thursday, November 7th. The company reported $0.33 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.33. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. The business had revenue of $478.71 million during the quarter, compared to analyst estimates of $462.01 million. During the same quarter in the previous year, the firm posted $0.47 EPS. As a group, analysts forecast that Astrana Health, Inc. will post 1.16 EPS for the current year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.